Blog
RSS FeedPosted by Michael Wonder on 28 May 2020
Fauci warns about hydroxychloroquine
27 May 2020 - Top administration expert airs differences with Trump on pandemic response. ...
Posted by Michael Wonder on 28 May 2020
‘Vaccine nationalism’: a new dynamic in the race to quash coronavirus
27 May 2020 - International pursuit for a shot is shifting into a contest of which world power can immunise its ...
Posted by Michael Wonder on 28 May 2020
COVID-19: researchers halt patient recruitment for hydroxychloroquine trial
28 May 2020 - Australian researchers have suspended patient recruitment in a major clinical trial of the controversial anti-malaria drug ...
Posted by Michael Wonder on 28 May 2020
European medicines regulatory network fully mobilised in fight against COVID-19
28 May 2020 - The development and availability of medicines and vaccines for all patients in the European Union, including those ...
Posted by Michael Wonder on 28 May 2020
Tax payers paid to develop remdesivir but will have no say when Gilead sets the price
27 May 2020 - Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus ...
Posted by Michael Wonder on 28 May 2020
Australia avoids 'risky business' of coronavirus vaccine sweepstakes
27 May 2020 - Australia is avoiding huge financial risks by staying out of the global sweepstakes on coronavirus vaccines. ...
Posted by Michael Wonder on 27 May 2020
COVID-19: UK authorises anti-viral drug remdesivir
26 May 2020 - A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is ...
Posted by Michael Wonder on 27 May 2020
EMA commissions independent research to prepare for real world monitoring of COVID-19 vaccines
27 May 2020 - EMA is engaging early with researchers to ensure that a European infrastructure will be in place to ...
Posted by Michael Wonder on 26 May 2020
WHO pauses hydroxycholoroquine arm in COVID-19 trial
26 May 2020 - The World Health Organisation has announced a temporary pause on a clinical trial arm testing hydroxycholoroquine ...
Posted by Michael Wonder on 26 May 2020
EMA calls for high-quality observational research in context of COVID-19
26 May 2020 - For observational studies of real world data in COVID-19, EMA calls for transparency for protocols and results, ...
Posted by Michael Wonder on 26 May 2020
Australians stick with malaria drug hydroxychoroquine trial
26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one ...
Posted by Michael Wonder on 25 May 2020
SMC response to COVID-19
22 May 2020 - To prioritise and support the capacity of health and social care services, Healthcare Improvement Scotland and the ...
Posted by Michael Wonder on 25 May 2020
First generic version of Gilead’s remdesivir will be sold by a Bangladesh drug maker
22 May 2020 - A drug maker in Bangladesh has become the first company to sell a generic version of ...
Posted by Michael Wonder on 25 May 2020
Inside the science: companies racing to develop a COVID-19 vaccine
25 May 2020 - Even as some states move to ease the lockdowns that have cost tens of millions of ...
Posted by Michael Wonder on 25 May 2020
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
26 May 2020 - The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to ...